Friday, April 24, 2026
33 C
Bengaluru

Pharma Marketing & The Reinvention

[wpfilebase tag=file id=105 tpl=download-button /]

Inside this Issue

1. Pharma Marketing & the Reinvention of the Pharma Company by  Salil Kallianpur

Digitization and shifting customer expectations are redefining the traditional role of a pharma company – how can marketing keep pace?

2. 5 Minute Guide to Professional Sales Management in in the Digital Age by Anirudha Sengupta

A quick reminder on what it takes to succeed in the age of shrinking in-clinic time and expanding information sources

3. Market Segmentation for the Digital Age by Vivek Hattangadi

The wealth of information contained in the digital footprint of customers, means that segmentation is no longer simply about age, gender and a few interests

4. Book Review: Catalyst by Chandramouli Venkatesan  by Rajeev Kumar

A career growth manual that emphasizes professional growth as an outcome of “real individual growth”

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of February 2018

Download the issue here: PDF

Hot this week

Is Pharma M&A Slowing Down Amidst Geopolitical Friction?

The pharmaceutical industry stands at a critical juncture in...

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

Topics

Is Pharma M&A Slowing Down Amidst Geopolitical Friction?

The pharmaceutical industry stands at a critical juncture in...

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...
spot_img

Related Articles

spot_imgspot_img